The Electrochemical Society

Adjusting to a Changed World

Mark Orazem on a Sabbatical that Doesn’t go According to Plan
11-Aug-2020 12:45 PM EDT, by The Electrochemical Society

Sabbatical goal achieved: Book proposal to ECS Monograph Series

Newswise — “The main purpose of my sabbatical has been working on a book with my collaborator, Bernard Tribollet. On previous sabbaticals over the past 25 years, I’ve travelled to Paris to collaborate with him. Bernard and I published a book on electrochemical impedance spectroscopy in 2008, and the second edition was published in 2017. What we’re working on now—remotely—is basically a problem-solving book. I am happy to say that one of my goals for the year, to start the process on that book, was accomplished. We wrote the proposal and submitted it to Wiley to be considered for publication as part of the ECS monograph series.”

Sabbatical plans for travel interrupted

“I went to Santiago, Chile, and to the University of Seville in Spain. Then health issues prevented me taking a trip to China in December—glad I didn’t go! I was also supposed to lecture at the university in Prague in mid-April. But by early March, it was clear that the world was facing a real problem. So I postponed that trip. At that point, UF was saying, ‘We don’t want you to travel. We’re not forbidding it, but we discourage foreign travel.’  So I advised ECS that it would be difficult for me to attend the Montreal meeting. The Society canceled the meeting, which was the right thing to do. 

I was scheduled to give my short course on chemical industrial safety at the Montreal meeting. I’ve been teaching this for the Society since 2000. It’s popular and I’m supposed to teach the course at PRiME. I’m scheduled to chair a session there and submitted a couple of abstracts. I want to attend PRiME, but I haven’t been as aggressive about preparing for it as I normally would be. It’s not clear if it will be safe to travel by October. The experts tell us there are certain things that need to happen; it doesn’t seem that they are.” 

Prolonging the pandemic pivot

“I return to teaching in the fall. My research is in electrochemistry and electrochemical engineering, but I teach industrial safety, on how to recognize and mitigate risky situations in a company environment. I’m really grateful that I didn’t suddenly have to pivot to online teaching. I’ve got time to think about it and talk with people whose teaching I respect. All UF courses were online as of March. The university anticipates that fall term will also be online. I am sure I can learn from my colleagues who transitioned their courses within weeks. They came up with good ideas. 

Even though I am on sabbatical, I still manage my research group. The way I work with my students is very interactive. On campus, my office is right across the hall from my students’ labs. I frequently walk through the lab, talk to people, and see what they’re doing. We have weekly formal individual and group meetings, now via Zoom. 

My students have continued their research which is probably about 60 percent modeling and 40 percent experimental. They do more modeling work, with remote access to all the software. However, there are experiments that we can’t do right now. We are waiting until UF decides it’s safe for us to return to the lab. 

I think that I should teach an online version of my ECS short course. When the monograph is done, maybe. I’m juggling a lot of balls!”

It’s all about interaction

“Though I do present papers, attend sessions, and deliver my short course, the primary reason I go to ECS meetings is to engage with colleagues in my field. You can do a lot one-on-one virtually, but something unique is gained in person. The connections I’ve made with people all over the world mean a lot to me. For example, early on I received a surprise shipment of masks from a colleague in China. His personal note shared what he had learned from his community‘s experience. It was very touching and helpful, especially when my wife and daughter were ill.

My fall course will be part lecture, part videos, and a few guest speakers ‘Zooming in’ from OSHA or other places. I don’t like using mostly PowerPoint in my lectures because it creates a barrier—and more so on Zoom. I’m going to broadcast what I write during a lecture on a pad of paper, the same way I would write on the blackboard.

Probably my biggest concern is how to recreate class engagement remotely. In my group meetings, I’ve started asking my students to share a two-slide summary of what they’ve been doing. In addition to that, once per semester, each student will present a safety moment or deliver a conference-style presentation. It’s good practice for them. Everyone gets to know what everyone else in the group is doing, creating a group rapport. Everyone seems to love it.”




Filters close

Showing results

1120 of 3765
Newswise: Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Released: 23-Oct-2020 10:40 AM EDT
Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Michigan Medicine - University of Michigan

What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Oct-2020 11:00 AM EDT Released to reporters: 23-Oct-2020 8:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Oct-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Released: 22-Oct-2020 2:40 PM EDT
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
University of Maryland Medical Center

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 22-Oct-2020 2:25 PM EDT
Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
Massachusetts General Hospital

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH).

Released: 22-Oct-2020 2:10 PM EDT
New York Gov. Andrew Cuomo said that nursing homes "never needed" to accept patients who tested positive for COVID-19, but they did accept them
Newswise

According to a report from the New York State Department of Health, "6,326 COVID-positive residents were admitted to [nursing home] facilities" following Cuomo's mandate that nursing homes accept the readmission of COVID-positive patients from hospitals. Therefore we rate his claim as false.

Released: 22-Oct-2020 2:10 PM EDT
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

Newswise: UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
Released: 22-Oct-2020 1:50 PM EDT
UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
University of Nevada, Las Vegas (UNLV)

As the race for a COVID-19 vaccine intensifies, health care officials are reminding the public not to forget another important vaccine this fall: the flu shot. Flu season in the U.S. technically began in September, with illnesses expected to peak in December and February, according to the Centers for Disease Control (CDC). Less than half of Americans received a flu vaccine during the 2019-2020 flu season, and a staggering 405,000 hospitalizations and 22,000 deaths were attributed to influenza.

Newswise: 246630_web.jpg
Released: 22-Oct-2020 1:45 PM EDT
Immune response the probable underlying cause of neural damage in COVID-19
University of Gothenburg

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

Released: 22-Oct-2020 1:35 PM EDT
COVID-19 study: Meaning in life and self-control protect against stress
University of Innsbruck

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

Newswise: Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Released: 22-Oct-2020 1:30 PM EDT
Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Hackensack Meridian Health

A new portable “lab on a chip,” developed by the U-M scientists and demonstrated with help of the CDI, can identify the presence of COVID-19 antibodies in blood donors with greater speed and efficiency


Showing results

1120 of 3765

close
0.96737